MedPath

An exploratory study on the impact of Baduanjin on short-term glucose variability among patients with type 2 diabetes mellitus

Phase 1
Conditions
Diabetes mellitus
Registration Number
ITMCTR2000003366
Lead Sponsor
Beijing University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Patients who meet the World Health Organization's diagnostic criteria for type 2 diabetes in 1999;
2. Patients diagnosed with type 2 diabetes for more than one year;
3. Patients over 60 years old;
4. The control of blood glucose was stable, that is, the HbA1c value in the past 3 months was less than 7%;
5. Patients who only use oral hypoglycemic drugs to control blood sugar;
6. Patients who voluntarily participated in the study and agreed to sign informed consent.

Exclusion Criteria

1. Patients who can't do Baduanjin Exercise due to illness;
2. Patients who are unable to wear the sensor of instant scanning blood glucose monitoring system due to local skin condition or allergy;
3. Patients who take VC, aspirin, local severe edema or peripheral blood circulation disorders, etc. to affect the blood glucose monitoring results;
4. Patients who have practiced Baduanjin regularly or other exercises regularly (those who exercise three or more times a week for 30 minutes or more each time).

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean blood glucose;Standard deviation of blood glucose;Time in Range;Episode of hypoglycemia;Mean Amplitude of Glucose Excursions;Mean of Daily Differences;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath